+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CHOKSILA CHOKSILA

Choksi Laboratories Share Price

₹118.20 +0 (0%)
50.06% Fall from 52W High

07 Aug, 2026 4:00 PM (IST)

Choksi Laboratories live price: ₹118.20. It opened at ₹118 vs previous close ₹118; intraday high/low: ₹118/₹112. The 50 & 200 DMA stand at ₹116.60/₹121.20.

Choksi Laboratories Performance

  • Today's Low
  • ₹112
  • Today's High
  • ₹118
  • 52 Week Low
  • ₹82
  • 52 Week High
  • ₹237
  • Open Price₹118
  • Previous Close₹118
  • Volume863
  • 50 DMA₹116.60
  • 100 DMA₹116.70
  • 200 DMA₹121.20

Choksi Laboratories Chart

Investment Returns

  • Over 1 Month -3.11%
  • Over 3 Month + 18.62%
  • Over 6 Month + 1.03%
  • Over 1 Year -40.72%

Smart Investing Starts Here Start SIP with Choksi Laboratories for Steady Growth!

Invest Now

Choksi Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 41.9
  • PEG Ratio
  • 1.4
  • Market Cap Cr
  • 82
  • P/B Ratio
  • 3.2
  • Average True Range
  • 7
  • EPS
  • 2.8
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.4
  • RSI
  • 51.68
  • MFI
  • 67.21

Latest Stock News Updates

Choksi Laboratories Ltd - 526546 - Board Meeting Intimation for Meeting Of Directors To Be Held On 13Th August, 2026

Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter ended on 30th June 2026; 2. To consider the appointment of Internal Auditor of the Company for the F.Y. 2026-27; 3. To consider the matters relating to the ensuing Annual General Meeting; 4. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting, which shall include at least one independent Director. If any

Choksi Laboratories Ltd - 526546 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication of information regarding change of RTA

Choksi Laboratories Ltd - 526546 - Announcement under Regulation 30 (LODR)-Change in RTA

Intimation for change of RTA in pursuant to Regulation 30 of SEBI (LODR) 2015

Choksi Laboratories Financials

Choksi Laboratories Technicals

EMA & SMA

Current Price
₹118.20
0 (0%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹117.10
  • 50 Day
  • ₹116.60
  • 100 Day
  • ₹116.70
  • 200 Day
  • ₹121.20

Resistance and Support

116.27 Pivot Speed
  • R3 125.90
  • R2 122.10
  • R1 120.10
  • S1 114.30
  • S2 110.50
  • S3 108.50

Choksi Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-13 Quarterly Results & A.G.M.
2026-05-25 Audited Results
2026-05-18 Others Inter-alia, to consider 1. Approve the purchase of Car for the business purposes & to avail credit facilities from Bank. 2. Change of Registrar & Share Transfer Agent (RTA). 3.Other business matters.
2026-02-07 Quarterly Results
2025-11-14 Quarterly Results

Choksi Laboratories Shareholding Pattern

61.49%
31.48%
7.02%
0%

About Choksi Laboratories

Choksi Laboratories is engaged in the sole segment of Analysis and Testing. View More
  • NSE Symbol
  • CHOKSILA
  • BSE Symbol
  • 526546
  • Chairman.,Executive Director,Managing Director,Chief Executive Officer
  • Sunil Choksi
  • ISIN
  • INE493D01013

Similar Stocks to Choksi Laboratories

Choksi Laboratories FAQs

Choksi Laboratories share price is ₹118 As on 08 August, 2026 | 09:16

The Market Cap of Choksi Laboratories is ₹82.3 Cr As on 08 August, 2026 | 09:16

The P/E ratio of Choksi Laboratories is 41.9 As on 08 August, 2026 | 09:16

The PB ratio of Choksi Laboratories is 3.2 As on 08 August, 2026 | 09:16

The 52 week High & Low of Choksi Laboratories is ₹236.7/₹81.8 respectively As on 08 August, 2026 | 09:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23